Location
United States, North America
Cheque size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
Consumer Health
Retail
Wellness & Fitness
About Investor
Daniel Goldberg is a Partner at Palo Santo, a venture capital firm investing in neuroscience, mental health therapeutics, psychedelic medicine, and biotechnology. He is also Co-Founder and Principal at Bridge Investments, with extensive experience in early-stage technology and consumer investing. Palo Santo's portfolio includes AtaiBeckley, Gilgamesh Pharmaceuticals, Transcend Therapeutics, and Beacon Biosignals. He remains actively involved in venture investing and the development of breakthrough treatments for mental health.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.
